Literature DB >> 24352363

Drug development: Releasing the brakes.

Karen Weintraub.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24352363     DOI: 10.1038/504S6a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

2.  Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.

Authors:  Omid Hamid; Caroline Robert; Adil Daud; F Stephen Hodi; Wen-Jen Hwu; Richard Kefford; Jedd D Wolchok; Peter Hersey; Richard W Joseph; Jeffrey S Weber; Roxana Dronca; Tara C Gangadhar; Amita Patnaik; Hassane Zarour; Anthony M Joshua; Kevin Gergich; Jeroen Elassaiss-Schaap; Alain Algazi; Christine Mateus; Peter Boasberg; Paul C Tumeh; Bartosz Chmielowski; Scot W Ebbinghaus; Xiaoyun Nicole Li; S Peter Kang; Antoni Ribas
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

3.  Nivolumab plus ipilimumab in advanced melanoma.

Authors:  Jedd D Wolchok; Harriet Kluger; Margaret K Callahan; Michael A Postow; Naiyer A Rizvi; Alexander M Lesokhin; Neil H Segal; Charlotte E Ariyan; Ruth-Ann Gordon; Kathleen Reed; Matthew M Burke; Anne Caldwell; Stephanie A Kronenberg; Blessing U Agunwamba; Xiaoling Zhang; Israel Lowy; Hector David Inzunza; William Feely; Christine E Horak; Quan Hong; Alan J Korman; Jon M Wigginton; Ashok Gupta; Mario Sznol
Journal:  N Engl J Med       Date:  2013-06-02       Impact factor: 91.245

  3 in total
  8 in total

1.  Immunological characterization of a rigid α-Tn mimetic on murine iNKT and human NK cells.

Authors:  Silvia Fallarini; Alvaro Brittoli; Michele Fiore; Grazia Lombardi; Olivier Renaudet; Barbara Richichi; Cristina Nativi
Journal:  Glycoconj J       Date:  2017-06-01       Impact factor: 2.916

2.  In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanoma.

Authors:  Ekaterina I Galanzha; Yulian A Menyaev; Aayire C Yadem; Mustafa Sarimollaoglu; Mazen A Juratli; Dmitry A Nedosekin; Stephen R Foster; Azemat Jamshidi-Parsian; Eric R Siegel; Issam Makhoul; Laura F Hutchins; James Y Suen; Vladimir P Zharov
Journal:  Sci Transl Med       Date:  2019-06-12       Impact factor: 19.319

Review 3.  Trial Watch: Peptide-based anticancer vaccines.

Authors:  Jonathan Pol; Norma Bloy; Aitziber Buqué; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-01-09       Impact factor: 8.110

Review 4.  The Advanced Practice Provider Perspective: Treating Patients With Immuno-Oncology Combination Therapy Across Tumor Types.

Authors:  Brianna Hoffner; Renae Vaughn; Maureen Reed; Melinda S Weber
Journal:  J Adv Pract Oncol       Date:  2019-03-01

5.  Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors.

Authors:  Nicola J Mason; Nicholas Chester; Ailian Xiong; Antonia Rotolo; Ying Wu; Sho Yoshimoto; Patrick Glassman; Gayathri Gulendran; Don L Siegel
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

6.  Trial watch: Immunostimulatory cytokines in cancer therapy.

Authors:  Erika Vacchelli; Fernando Aranda; Florine Obrist; Alexander Eggermont; Jérôme Galon; Isabelle Cremer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-06-03       Impact factor: 8.110

7.  Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.

Authors:  Katie L Anderson; Jaime F Modiano
Journal:  Vet Sci       Date:  2015-10-19

Review 8.  Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: a short review.

Authors:  Jennifer M Yoest
Journal:  Immunotargets Ther       Date:  2017-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.